bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.7890
-0.0410 (-4.94%)
At close: Jul 8, 2026, 4:00 PM EDT
0.7715
-0.0175 (-2.22%)
Pre-market: Jul 9, 2026, 6:05 AM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $3.57 million as of July 9, 2026. Its market cap has decreased by -43.59% in one year.
Market Cap
3.57M
Enterprise Value
1.86M
1-Year Change
-43.59%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $3.57M, a decrease of -92.06%. That is a compound annual growth rate of -48.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 3.57M | -32.55% |
| Dec 31, 2025 | 5.30M | -62.63% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
| Sep 1, 2022 | 45.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Insight Molecular Diagnostics | 154.35M |
| Burning Rock Biotech | 123.39M |
| Exagen | 107.99M |
| Precipio | 47.19M |
| MDxHealth | 25.06M |
| Quantum Cyber | 19.21M |
| Advanced Biomed | 8.26M |
| Check-Cap | 8.24M |